(Total Views: 402)
Posted On: 06/03/2019 7:10:56 PM
Post# of 158219
Thanks for sharing! I have read this article and it has a lot of useful information even if published in 2008.
One thing I recall and pertains to the CAR-T deletion of CCR5 is this was viewed positively, and thus I was concerned about it being a competitor to leronlimab (when doing my earlier DD). I know these will take quite a bit more time for approval if that ever happens, so I didn’t let that keep me from pursuing CYDY.
One thing I recall and pertains to the CAR-T deletion of CCR5 is this was viewed positively, and thus I was concerned about it being a competitor to leronlimab (when doing my earlier DD). I know these will take quite a bit more time for approval if that ever happens, so I didn’t let that keep me from pursuing CYDY.
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
